Jonathan Slonin - Jul 5, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Clinical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jul 5, 2022
Transactions value $
-$52,842
Form type
4
Date filed
7/7/2022, 07:04 PM
Previous filing
Jun 8, 2022
Next filing
Aug 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$52.8K -924 -2.41% $57.19 37.4K Jul 5, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes 214 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.